Oncolytics Biotech Inc ONCY

Great Results

[Quentin30]

Great Results, yet more compelling evidence... but nothing statisically significant.

Interestingly they chose not to mention the possibility of Accelerated Approval with these results... (but that isn't a surprise)... never mind, I'm sure Mr Noteable can copy and paste something of no relevance on this. perhaps he can get a different job working in ONCY's PR dept.

Great OS data is excellent, and the market would think it even more excellent if it weren't on just a handful of patients... we waited 4 years for this data...!!

So, 

• Oncolytics Biotech is moving forward to secure funding for a registration-enabling study of pelareorep-based therapy in advanced or metastatic breast cancer

so, they need to wirte the protocol, get it approved, get the study sites in place... so experience of ONCY would suggest this trial could start in Q2 2025. Getting the funding though... that's a tough one... as they failed to capitalise on their partnership with Adlai Nortye, and after 10+ years of saying they are in discussions with Big Pharma, one would think funding this next "registration-enabling" study would be easy....

Anyone any ideas in how they might raise 80 million..??

[jh1970]

Financing  100M shares at $0.8  , maybe.

[CMHarring218431]

Now is the time for promotion. They should be soliciting recognizable and respected analysts to review results in the hope of getting a positive  nod and perhaps a recommendation. Flood the editors of medical journals with the results. Just get the word out and perhaps it will entice possible funding 0pportunities

[Journeytc]

Some way out there thoughts.  Heineman stated "we wont be going head to head with the ADCs".  Strange wording as it implies they could.  Sounds like the swesome Bracelet overall survival result triumphs which is the only thing that matters.  ONC seems to be giving assurance ... please dont worry about your profits Pfizer and FDA.  ONC is a weakling in this